Erickson P, et al. - Using data from the Maryland Non-Small Cell Lung Cancer (NSCLC) Case-Control Study (1,220 cases [404 African Americans (AA) and 816 European Americans (EA)] and 1,634 controls [1,004 EA and 630 AA]), researchers examined whether use, frequency, and duration of the anti-inflammatory drug aspirin was linked with lung cancer risk and survival, separately among AA and EA populations. Findings suggested an association of aspirin use with lower risk of NSCLC among men and improved survival among AA. Data reported that Tylenol and other NSAIDs were either correlated with elevated or no NSCLC risk.